Vera Therapeutics Overview
Vera Therapeutics Target Price
Analysts' 12-month price predictions for VERA.
Get informed when a big investor buys or sells
+ FollowShare Price
$41.2
Average Target Price
$80.33
95% upside
95% upside3 analysts in the last 4 months
High: $91 | Low: $60
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-02 | JefferiesFarzin Haque | $60 | 45.6% upside |  |
| 2026-06-02 | Goldman SachsPaul Choi | $90 | 118.4% upside | |
| 2026-05-15 | Evercore ISI | $91 | 120.9% upside | |
| 2025-12-19 | Goldman Sachs | $95 | 130.6% upside | |
| 2025-12-11 | WedbushLaura Chico | $33 |  19.9% downside | |
| 2025-12-08 | Evercore ISIGavin Clark-Gartner | $97 | 135.4% upside | |
| 2025-12-05 | Pivotal Research | $73 | 77.2% upside | |
| 2025-11-28 | H.C. Wainwright | $90 | 118.4% upside | |
| 2025-06-03 | ScotiabankGreg Harrison | $65 | 57.8% upside | |
| 2024-03-21 | WedbushLaura Chico | $34 | 17.5% downside | |
| 2024-01-26 | Raymond JamesRyan Deschner | $37 | 10.2% downside | |
| 2023-12-18 | Raymond JamesRyan Deschner | $29 | 29.6% downside | |
| 2023-01-04 | Jefferies | $6 | 85.4% downside | |
| 2023-01-04 | H.C. Wainwright | $15 | 63.6% downside | |
| 2022-11-18 | J.P. Morgan | $38 | 7.8% downside | |
| 2022-05-02 | H.C. Wainwright | $35 | 15% downside | |